Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • US debt ceiling deadline pushed back as talks continue
    • ‘War over water’: drought battle reaches luxury pools of southern France
    • ‘Outraged and furious’: Germans rebel against gas boiler ban
    • Biden and McCarthy speak in bid to reach debt ceiling deal
    • Portugal paves way to a Huawei ban on country’s 5G network
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • Sky to cut hundreds of jobs in shift from satellite TV
      • Beverly Hills voters reject LVMH luxury hotel on Rodeo Drive
      • EY US reshuffles leadership following failure of spin-off plan
      • Jamie Dimon gathers business elite in Shanghai amid China-US tensions
      • BA passengers severely disrupted as 160 flights are cancelled ahead of holiday weekend
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Weddings and divorce: the scourge of investment returns
      • Investors expect higher interest rates as inflation pressures mount
      • Is COP28 destined to be a flop?
      • Flight risk? London listings are the most vulnerable to New York’s allure
      • Private equity investment trust discounts widen
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • Weddings and divorce: the scourge of investment returns
      • Buffett’s intriguing bet on Japan
      • A stylist, yes, but Martin Amis was also right on the money
      • Letter from the editor on generative AI and the FT
      • The futile pursuit of good taste
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Germany’s tangled relationship with Russia
      • Economist Daniel Chandler: ‘Shareholders have all the power. It doesn’t have to be that way.’
      • Wellcome Leap’s Regina Dugan: ‘Odds are irrelevant, if what you’re trying to do is important’
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • GCHQ’s Jeremy Fleming: ‘Xi doesn’t want to see Putin humiliated’
      • The UK’s best bakeries: the readers’ picks
      • From Bowie to Jagger, the photos that created legends
      • We need to talk about picnics
      • Homes on screen: how scouts find the perfect film locations
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Johnson & Johnson Co Inc

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Friday, 5 May, 2023
      Special ReportAsia-Pacific Innovative Lawyers
      In-house legal work: best practice case studies

      Examples of innovative services and advice developed by legal teams in Asia-Pacific

    • Thursday, 4 May, 2023
      J&J consumer arm’s shares jump in biggest US IPO since 2021

      Kenvue valued at $41bn after carve-out from US healthcare group

    • Thursday, 27 April, 2023
      Talcum powder cancer claims target J&J’s new consumer carve-out

      Executives had tried to shield Kenvue from most of the asbestos lawsuits already facing the group

    • Tuesday, 18 April, 2023
      Johnson & Johnson reports loss after taking $6.9bn charge over talc claims

      Healthcare group to ask judge to halt lawsuits over talcum powder linked to cancer under auspices of bankruptcy system

    • Wednesday, 5 April, 2023
      Lex
      Johnson & Johnson: talc settlement shows virtues of Chapter 11 process Premium content

      US bankruptcy may be a tolerable, if imperfect, forum for resolving these cases

    • Tuesday, 4 April, 2023
      Johnson & Johnson proposes $8.9bn talc settlement

      Healthcare company tries to put thousands of lawsuits behind it with latest offer to plaintiffs

    • Tuesday, 7 February, 2023
      FT News Briefing podcast9 min listen
      The jig is up for the Texas two-step

      UK to design ‘digital pound’ that could fend off a future private tech rival

    • Monday, 6 February, 2023
      News in-depthBankruptcy
      Talc ruling a blow to J&J and the ‘Texas two-step’ bankruptcy jig

      Ruling by US court will make companies think twice about using Chapter 11 schemes to handle lawsuits

    • Tuesday, 31 January, 2023
      Lex
      J&J: court stops the music for the ‘Texas two-step’ Premium content

      Congress may eventually have to step in and create a new club to resolve mass torts

    • Monday, 30 January, 2023
      J&J blocked from using bankruptcy to resolve talcum powder lawsuits

      Ruling from US appeals court casts doubt on future of contentious ‘Texas two-step’ manoeuvre

    • Thursday, 5 January, 2023
      Lex
      J&J/Kenvue: IPO will test investor appetite Premium content

      A successful listing would focus J&J on its pharmaceutical and medical-device business

    • Tuesday, 1 November, 2022
      Lex
      J&J/Abiomed: healthcare giant pays high price to bulk up on medtech Premium content

      EV/ebitda multiple is rich, given the healthcare giant expects any potential cost savings to be ‘very modest’

    • Tuesday, 1 November, 2022
      Johnson & Johnson bucks global M&A slowdown with $16.6bn Abiomed deal

      Purchase of heart pumpmaker to help US pharma group focus on drugs and medical devices

    • Tuesday, 25 October, 2022
      The Big Read
      ‘Texas two-step’: the US legal move letting corporations off the hook

      Critics say the controversial legal manoeuvre allows companies to bypass their responsibilities. But judges are beginning to crack down

    • Monday, 22 August, 2022
      J&J tries to extend its ‘Texas two-step’ to halt two states’ talc cases

      New Mexico and Mississippi say consumer company’s strategy is making a ‘mockery’ of bankruptcy law

    • Tuesday, 19 July, 2022
      J&J blames US dollar strength for second outlook cut in as many quarters

      Pharmaceutical group issues downbeat forecast despite better than expected quarterly results

    • Tuesday, 21 June, 2022
      Behind the Money podcast28 min listen
      Inside Johnson & Johnson’s bankruptcy two-step

      This legal manoeuvre is setting a new precedent for corporations to evade accountability in America

    • Sunday, 6 March, 2022
      J&J targets Chinese biotech deals as western pharma groups look east

      US drugmaker seeks more tie-ups after existing collaboration yields new cancer treatment

    • Tuesday, 1 March, 2022
      LexBankruptcy
      US bankruptcy/J&J: new turn for Texas two-step Premium content

      Ruling opens a fresh chapter for resolving US tort cases

    • Monday, 28 February, 2022
      Health
      US lawmakers plan bill to outlaw ‘Texas two-step’ bankruptcy ploy

      Fight moves to Congress after judge allows J&J to use scheme to help it settle billions in legal claims

    • Friday, 25 February, 2022
      Johnson & Johnson can proceed with controversial bankruptcy strategy, judge rules

      Decision allows group to use the manoeuvre to manage tens of thousands of claims that its baby talc caused cancer

    • Monday, 14 February, 2022
      Legal services
      Architects of ‘Texas two-step’ lambast J&J for its use of the manoeuvre

      Lawyer who drafted statute says companies should not deploy it to ‘skirt’ their obligations

    • Thursday, 6 January, 2022
      Covid-19 vaccines
      Covid vaccine makers face investor pressure over global access

      Asset managers call for pharma executive pay to be linked to equitable distribution of jabs

    • Thursday, 30 December, 2021
      Covid-19 vaccines
      Johnson & Johnson booster slashes risk of Omicron hospitalisation, study shows

      Two doses cut likelihood by up to 85%, according to real-world South African research

    • Sunday, 12 December, 2021
      South Africa
      South Africa’s leader Cyril Ramaphosa tests positive for Covid

      Country tackles one of the first waves of infections caused by Omicron variant

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In